跳至主要内容
临床试验/CTRI/2018/08/015555
CTRI/2018/08/015555已完成未知

A clinical assessment to evaluate the effect of two different combinations of anti-hypertensive drugs (Telmisartan 40 mg plus Amlodipine 5 mg and Telmisartan 40 mg plus Cilnidipine 10 mg among Subjects with uncontrolled hypertension in India â?? A prospective, randomized, investigator initiated study.

Current Medical Concepts Pvt Ltd0 个研究点目标入组 93 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
93

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a) Adults greater than or equal to 18 years and
  • less than or equal to 70 years old both male
  • and female.
  • b) Subjects with uncontrolled BP who are on
  • monotherapy.
  • c) Systolic Blood Pressure (SBP) >130 mmHg and
  • Diastolic Blood Pressure (DBP) > 80
  • mmHg based on three consecutive blood
  • pressure readings
  • d) Any stage of Hypertension.
  • e) Willing to give written informed consent

排除标准

  • a) Women of child bearing potential
  • b) History of Myocardial infarction, Acute
  • stroke, Acute kidney injury in the last 3
  • c) Subjects with history of congestive heart
  • d) Subjects with advanced CKD with Serum
  • Creatinine value > 2.5 mg/dL.
  • e) History of allergy to calcium channel
  • blockers and angiotensin receptor blockers
  • f) Inability to give informed consent
  • g) Subject with hypertensive crisis (Seated BP
  • greater than or equal to 180/120 mmHg) on
  • the day of screening.
  • h) Subjects unwilling/unable to adhere to the
  • study protocol.

研究者

发起方
Current Medical Concepts Pvt Ltd

相似试验